论文部分内容阅读
美国专利和商标局(PTO)终于通过了这一长期以来似乎是不可避免的问题,即允许在高等动物遗传工程方面申请专利。美国将是实施这一政策的第一个国家。PTO说,尽管到目前为止还没有商业性的公司积极地准备生产rDNA高等动物,但它已经收到了15个关于多细胞生物体的专利申请。1980年,美国最高法院允许就细菌申请专利,最近又允许 rDNA 牡蛎申请专利,从这两件事来看,允许动物申请专利将成为必然。关于重组体牡蛎,PTO的上诉委员会曾拒绝接受该专利申请,但也说明了不能只因为它是一个高等生物体而加以拒
The U.S. Patent and Trademark Office (PTO) has finally adopted what seems to be an inevitable problem for a long time, allowing the patenting of higher animal genetic engineering. The United States will be the first country to implement this policy. The PTO said that although no commercial company has so far been actively preparing for the production of rDNA higher animals, it said it has received 15 patent applications for multicellular organisms. In 1980, the U.S. Supreme Court allowed the patenting of bacteria and recently allowed rDNA oysters to apply for patents. From these two perspectives, it would be inevitable that animals would be allowed to apply for a patent. With regard to the recombinant oyster, the PTO’s Appeals Board rejected the patent application but also stated that it should not be rejected merely because it is a higher organism